PL2065035T3 - Preparaty farmaceutyczne zawierające irbesartan - Google Patents
Preparaty farmaceutyczne zawierające irbesartanInfo
- Publication number
- PL2065035T3 PL2065035T3 PL07380332T PL07380332T PL2065035T3 PL 2065035 T3 PL2065035 T3 PL 2065035T3 PL 07380332 T PL07380332 T PL 07380332T PL 07380332 T PL07380332 T PL 07380332T PL 2065035 T3 PL2065035 T3 PL 2065035T3
- Authority
- PL
- Poland
- Prior art keywords
- pharmaceutical formulations
- formulations containing
- containing irbesartan
- irbesartan
- diuretic
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 3
- 239000002947 C09CA04 - Irbesartan Substances 0.000 title abstract 2
- YCPOHTHPUREGFM-UHFFFAOYSA-N irbesartan Chemical compound O=C1N(CC=2C=CC(=CC=2)C=2C(=CC=CC=2)C=2[N]N=NN=2)C(CCCC)=NC21CCCC2 YCPOHTHPUREGFM-UHFFFAOYSA-N 0.000 title abstract 2
- 229960002198 irbesartan Drugs 0.000 title abstract 2
- 239000002934 diuretic Substances 0.000 abstract 1
- 230000001882 diuretic effect Effects 0.000 abstract 1
- 238000009472 formulation Methods 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biophysics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP07380332A EP2065035B1 (en) | 2007-11-28 | 2007-11-28 | Pharmaceutical formulations containing irbesartan |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2065035T3 true PL2065035T3 (pl) | 2011-02-28 |
Family
ID=39356685
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL07380332T PL2065035T3 (pl) | 2007-11-28 | 2007-11-28 | Preparaty farmaceutyczne zawierające irbesartan |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US20090136571A1 (pl) |
| EP (1) | EP2065035B1 (pl) |
| AT (1) | ATE474558T1 (pl) |
| DE (1) | DE602007007968D1 (pl) |
| ES (1) | ES2349317T3 (pl) |
| PL (1) | PL2065035T3 (pl) |
| PT (1) | PT2065035E (pl) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103040841B (zh) * | 2013-01-09 | 2014-04-30 | 南京正大天晴制药有限公司 | 一种含厄贝沙坦和氢氯噻嗪的药物组合物 |
| CN105078913B (zh) * | 2014-05-22 | 2018-02-27 | 山东司邦得制药有限公司 | 一种厄贝沙坦片及其制备方法 |
| JP6668666B2 (ja) * | 2015-10-05 | 2020-03-18 | ニプロ株式会社 | イルベサルタンを含有する医薬組成物及びその製造方法 |
| CN113648281B (zh) * | 2021-09-24 | 2023-01-17 | 宁夏医科大学 | 一种多晶型厄贝沙坦纳米混悬液及其制备方法和应用 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3639168A (en) * | 1969-04-29 | 1972-02-01 | Sucrest Corp | Direct compression vehicles |
| US5270317A (en) * | 1990-03-20 | 1993-12-14 | Elf Sanofi | N-substituted heterocyclic derivatives, their preparation and the pharmaceutical compositions in which they are present |
| TW201738B (pl) | 1990-03-20 | 1993-03-11 | Sanofi Co | |
| FR2725987B1 (fr) | 1994-10-19 | 1997-01-10 | Sanofi Sa | Procede pour la preparation d'un derive de tetrazole sous deux formes cristallines et nouvelle forme cristalline de ce derive |
| US5994348A (en) * | 1995-06-07 | 1999-11-30 | Sanofi | Pharmaceutical compositions containing irbesartan |
| TW442301B (en) | 1995-06-07 | 2001-06-23 | Sanofi Synthelabo | Pharmaceutical compositions containing irbesartan |
| FR2780403B3 (fr) | 1998-06-24 | 2000-07-21 | Sanofi Sa | Nouvelle forme de l'irbesartan, procedes pour obtenir ladite forme et compositions pharmaceutiques en contenant |
| TR200301553A1 (tr) | 2003-09-18 | 2005-10-21 | Nobel �La� Sanay�� Ve T�Caret A.�. | İrbesartan etken maddesi içeren yeni oral farmasötik formülasyonlar |
| ES2282062T1 (es) * | 2004-06-04 | 2007-10-16 | Teva Pharmaceutical Industries Ltd. | Composicion farmaceutica que contiene irbesartan. |
| ES2259909B1 (es) | 2005-02-28 | 2007-06-16 | Inke, S.A. | Procedimiento para la obtencion de un compuesto farmaceuticamente activo y de su intermedio de sintesis. |
| DE102005031577A1 (de) * | 2005-07-06 | 2007-01-11 | Bayer Healthcare Ag | Pharmazeutische Darreichungsformen enthaltend eine Wirkstoffkombination von Nifedipin und/oder Nisoldipin und einem Angiotensin-II Antagonisten |
| ES2340701T3 (es) | 2006-01-09 | 2010-06-08 | Krka, D.D., Novo Mesto | Composicion farmaceutica solida que comprende irbesartan. |
| US20090030052A1 (en) | 2006-02-17 | 2009-01-29 | Alembic Limited | Pharmaceutical tablet compositions containing irbesartan |
-
2007
- 2007-11-28 ES ES07380332T patent/ES2349317T3/es active Active
- 2007-11-28 PT PT07380332T patent/PT2065035E/pt unknown
- 2007-11-28 DE DE602007007968T patent/DE602007007968D1/de active Active
- 2007-11-28 PL PL07380332T patent/PL2065035T3/pl unknown
- 2007-11-28 AT AT07380332T patent/ATE474558T1/de not_active IP Right Cessation
- 2007-11-28 EP EP07380332A patent/EP2065035B1/en not_active Not-in-force
-
2008
- 2008-04-30 US US12/112,808 patent/US20090136571A1/en not_active Abandoned
-
2011
- 2011-05-23 US US13/113,300 patent/US20110223211A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| PT2065035E (pt) | 2010-10-04 |
| EP2065035A1 (en) | 2009-06-03 |
| DE602007007968D1 (de) | 2010-09-02 |
| EP2065035B1 (en) | 2010-07-21 |
| ATE474558T1 (de) | 2010-08-15 |
| ES2349317T3 (es) | 2010-12-29 |
| US20110223211A1 (en) | 2011-09-15 |
| US20090136571A1 (en) | 2009-05-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL2364983T3 (pl) | Nowa pochodna tricykliczna lub jej farmaceutycznie dopuszczalne sole, sposób jej wytwarzania, oraz zawierająca ją kompozycja farmaceutyczna | |
| WO2008154083A3 (en) | Compounds, compositions and methods for the treatment of synucleinopathies | |
| GEP20135744B (en) | Quinuclidine carbonate derivatives and medicinal compositions containing the same | |
| UA100393C2 (ru) | Новые офтальмологические композиции | |
| WO2009125434A3 (en) | Oxime derivatives, process for their preparation, pharmaceutical composition containing the same and medicinal use thereof | |
| UA93709C2 (ru) | 12-имидазолил-1-додеканол и его применение b изготовлении фармацевтических композиций | |
| MX2009013501A (es) | Compuestos piperidinicos y sus usos. | |
| TW200806282A (en) | Solid dosage formulations | |
| MY149854A (en) | Novel aminoalcohol-substituted aryldihydroisoquinolinones, process for their preparation and their use as medicaments | |
| WO2008006795A3 (en) | Indole compounds | |
| GEP20135806B (en) | Lactams as beta secretase inhibitors | |
| WO2010049449A3 (en) | Novel salts of sunitinib | |
| TNSN07337A1 (en) | Pharmaceutical composition comprising an indolylmaleimide derivative | |
| WO2008020306A3 (en) | Isoindole derivatives | |
| WO2008129501A3 (en) | Pharmaceutical compositions of duloxetine | |
| TW200626158A (en) | Naphthaline derivatives | |
| MY161749A (en) | Compound, certain novel forms thereof, pharmaceutical compositions thereof and methods for preparation and use | |
| MX2009003169A (es) | Derivados de sulfonamida. | |
| WO2010012459A3 (en) | A process for the preparation of solifenacin salts and their inclusion into pharmaceutical dosage forms | |
| WO2007111983A8 (en) | New therapeutic combinations for the treatment or prevention of psychotic disorders | |
| WO2010044097A3 (en) | Novel dosage form of paliperidone and process for preparing the same | |
| PL2065035T3 (pl) | Preparaty farmaceutyczne zawierające irbesartan | |
| MX2007006387A (es) | Derivados de piridina 3-substituidos como antagonistas h3. | |
| WO2007110765A3 (en) | Processes for the preparation of octreotide | |
| WO2006077024A3 (en) | 5-aminoindole derivatives |